Medicine News and Research

RSS

OGT awarded NHS tender to supply oligo-based arrays for cytogenetics

Oxford Gene Technology, provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics.

From Oxford Gene Technology 4 Feb 2014

NeuroRehabilitation showcases different approaches to restoring mental functioning

There is a growing need for Cognitive Rehabilitation Therapy (CRT) due to the huge influx of soldiers returning from war zones with brain injuries, athletes with sports-related head injuries, and the growing population with age-related cognitive decline.

4 Feb 2014

Researchers discover genetic mutations that cause deadly lung disease

A team of researchers, led by physicians and scientists at Intermountain Medical Center and ARUP Laboratories in Salt Lake City, has made a medical breakthrough by discovering genetic mutations that cause a rare and deadly lung disease.

4 Feb 2014

Study analyzing concussion data for NFL players may provide insight that could lead to safer play

A new study analyzing concussion data for NFL players during the16-game regular season schedules for 2012 and 2013 may provide insight that could lead to safer play, including a pathway for concussion-prevention strategies.

4 Feb 2014

Healthcare experts propose concrete steps for managing shortages of life-saving drugs

A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.

4 Feb 2014

Hy-Vee collaborates with UNMC and Ferris State to offer rapid-diagnostic influenza test

Getting tested and treated for the flu and strep throat became much easier today in Omaha. It's now as convenient as a trip to the grocery store.

4 Feb 2014

Pfizer’s palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Pfizer Inc. today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for the combination of palbociclib and letrozole compared with letrozole alone in post-menopausal women with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or newly diagnosed metastatic breast cancer.

4 Feb 2014

Researchers recommend FIT as screening tool for colorectal cancer

Tests that require patients to collect a single stool sample at home and then send it to a lab for analysis will detect about 79 percent of colorectal cancers, according to a new evidence review published in the Annals of Internal Medicine.

4 Feb 2014

Drug used to treat schizophrenia, dementia has potential for treating liver disease

Opening up a can of worms is a good way to start hunting for new drugs, recommend researchers from Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine.

4 Feb 2014

Efforts to reduce sudden unexpected infant death and prematurity can help close the gap

Researchers consider infant mortality to be a key indicator of population health. Currently, the United States ranks 27th among industrialized nations in infant mortality, but rates within the U.S. vary significantly by race, socioeconomic status, and geography.

4 Feb 2014

Biotheranostics launches complete genomic tests for metastatic cancer patients

bioTheranostics, Inc., today introduced the bioT3 Metastatic Cancer Solution, a suite of genomic-based tests that provide personalized diagnostic information and therapeutic guidance for metastatic cancer patients across the continuum of care.

4 Feb 2014

Cancer specialist takes efforts to improve survival rates across Europe

Queen's University Belfast's world renowned cancer specialist, Professor Patrick Johnston, whose work has transformed cancer care in Northern Ireland, is now leading efforts to improve survival rates across Europe.

4 Feb 2014

Complex intervention successful in reducing C-sections and neonatal morbities, say researchers

In a study to be presented on Feb. 6 in an oral plenary session at 8 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that Cesarean deliveries reviews and best practices implementation are effective to provide optimal care by an appropriate management of medical interventions, leading to a significant reduction of cesarean deliveries and neonatal morbidity.

4 Feb 2014

Gene involved in inflammation, blood clotting associated with cerebral palsy, death in very preterm babies

In a study to be presented on Feb. 6 at 2:45 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that a variant in SERPINE1, a gene involved in inflammation and blood clotting, is associated with cerebral palsy and death in very preterm babies.

4 Feb 2014

Study finds cervicovaginal microbiota differs in women destined to have preterm birth

In a study to be presented on Feb. 6 at 3:15 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that cervicovaginal (CV) microbiota differs in the late second and early third trimester in women destined to have a preterm birth.

4 Feb 2014

Researchers develop new self-assessment tool improve patient care in hospitals

A new assessment tool published today in the Journal of Hospital Medicine can help hospital medicine groups across the country improve their patient care and make their operations more effective.

4 Feb 2014

Chemical "signature" in blood may predict which AML patients would benefit from chemotherapy

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical "signature" in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.

4 Feb 2014

Researchers discover new signaling pathway that could impact treatment of autoinflammatory diseases

Researchers from Virginia Commonwealth University (VCU) Massey Cancer Center have discovered a new signaling pathway in sterile inflammation that could impact the treatment of diseases such as cancer, multiple sclerosis and rheumatoid arthritis.

4 Feb 2014

ACE protein overexpression elevates immune responses and prevents Alzheimer's-like cognitive decline

Many people with high blood pressure are familiar with ACE inhibitors, drugs that widen blood vessels by limiting activity of ACE - angiotensin-converting enzyme - a naturally occurring protein found in tissues throughout the body.

4 Feb 2014

Consumption of added sugar associated with increased risk for death from CVD

Many U.S. adults consume more added sugar (added in processing or preparing of foods, not naturally occurring as in fruits and fruit juices) than expert panels recommend for a healthy diet, and consumption of added sugar was associated with increased risk for death from cardiovascular disease (CVD), according to a study published by JAMA Internal Medicine, a JAMA Network publication.

4 Feb 2014

Medicine News and Research

OGT awarded NHS tender to supply oligo-based arrays for cytogenetics

NeuroRehabilitation showcases different approaches to restoring mental functioning

Researchers discover genetic mutations that cause deadly lung disease

Study analyzing concussion data for NFL players may provide insight that could lead to safer play

Healthcare experts propose concrete steps for managing shortages of life-saving drugs

Hy-Vee collaborates with UNMC and Ferris State to offer rapid-diagnostic influenza test

Pfizer’s palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Researchers recommend FIT as screening tool for colorectal cancer

Drug used to treat schizophrenia, dementia has potential for treating liver disease

Efforts to reduce sudden unexpected infant death and prematurity can help close the gap

Biotheranostics launches complete genomic tests for metastatic cancer patients

Cancer specialist takes efforts to improve survival rates across Europe

Complex intervention successful in reducing C-sections and neonatal morbities, say researchers

Gene involved in inflammation, blood clotting associated with cerebral palsy, death in very preterm babies

Study finds cervicovaginal microbiota differs in women destined to have preterm birth

Researchers develop new self-assessment tool improve patient care in hospitals

Chemical "signature" in blood may predict which AML patients would benefit from chemotherapy

Researchers discover new signaling pathway that could impact treatment of autoinflammatory diseases

ACE protein overexpression elevates immune responses and prevents Alzheimer's-like cognitive decline

Consumption of added sugar associated with increased risk for death from CVD

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News